Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PDA:TOLERATE: Early vs Conservative PDA Treatment
NCT01958320Phase 2Completed
- Sponsor
- University of California, San Francisco
- Start
- Dec 2013
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 2, randomised, open-label trial of indomethacin, ibuprofen and acetaminophen in patent ductus arteriosus (PDA) (2 arms), sponsored by University of California, San Francisco. Primary endpoint: Number of Infants Who Undergo in Hospital PDA Ligations or Who Have an Open Ductus at the Time of Discharge. Started Dec 2013; status: completed.
02
Drugs
indomethacinibuprofenacetaminophen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on NCT01958320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01958320.